MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2Peilong Li, Chuanxin Wang|Molecular Cancer Therapeutics|2017Cited by 249